ArticleInternational journal of colorectal disease2026
Utilisation of intramuscular and intermuscular fat to develop a new skeletal muscle grading score which can predict treatment outcomes for locally advanced rectal cancer.
Article in International journal of colorectal disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenia has been widely studied in rectal cancer with increasing evidence to suggest that other body composition parameters, in particular adipose tissue, have an important role. Advances in artificial intelligence (AI) now allow 3D body composition analysis of intermuscular/intramuscular adipose tissue (IMAT) from CT scans. This study aimed to develop and evaluate a skeletal muscle score (SMS), utilising skeletal muscle (SM) and IMAT measurements, to predict treatment response and survival outcomes for rectal cancer patients.
methodsA retrospective analysis was performed on 226 patients with localised rectal adenocarcinoma treated at Western Health between 2013 and 2024. Body composition metrics, including SM and IMAT volume and density from the L1-S5 vertebral region, were extracted using validated AI software. A SMS (0-4) was developed to predict overall complete response (oCR). The primary endpoint was oCR, defined as pathological complete response or sustained clinical complete response for at least 3 years. Secondary outcomes included overall, cancer-specific, and disease-free survival.
resultsAn oCR was achieved in 25.7% of patients and was significantly associated with a lower MRI T stage, increased age at diagnosis, and a better SMS, whilst active smoking decreased oCR in a multivariable analysis. Patients with an SMS of zero had a 0% oCR rate, whilst patients with a SMS of four had oCR rate of 60%. A higher SMS correlated with improved overall, cancer-specific, and disease-free survival.
conclusionThe SMS is a novel, AI-derived body composition assessment that is strongly correlated with treatment response and survival in rectal cancer patients. This scoring system could provide clinicians with individualised risk stratification to enhance patient counselling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.